Sellas Life Sciences SLS 深 滬
等待開盤 05-20 09:30:00 美东时间
7.59
+0.300
+4.12%
華盛通- 最 高7.625
- 今 開7.17
- 成交量 787.89万股
- 最 低 6.85
- 昨 收 7.29
- 總市值 14.12亿
- 52周最高 7.80
- 市盈率 靜 --
- 換手率 4.24%
- 52周最低 1.39
- 委 比 -90.66%
- 總股本 1.86亿
- 歷史最高 554.50
- 量 比 0.56
- 振 幅 10.63%
- 歷史最低 0.4986
- 每 手 1
- 風險率 1.49%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股夜盘 | CAVA Group涨7.10%，Sellas Life Sciences涨4.48%
CAVA Group涨7.10%；Sellas Life Sciences涨4.48%；POET Technologies涨4.13%
今天 15:01
美股夜盘 | CAVA Group, Inc.涨7.12%，Sellas Life Sciences涨6.85%
CAVA Group, Inc.涨7.12%；Sellas Life Sciences涨6.85%；Klaviyo, Inc. Class A涨3.27%
今天 13:01
美股夜盘 | Sellas Life Sciences涨8.56%，CAVA Group, Inc.涨7.04%
Sellas Life Sciences涨8.56%；CAVA Group, Inc.涨7.04%；Klaviyo, Inc. Class A涨5.85%
今天 10:01
美股夜盘 | Sellas Life Sciences涨7.51%，CAVA Group, Inc.涨7.27%
Sellas Life Sciences涨7.51%；CAVA Group, Inc.涨7.27%；Roblox Corp. Class A涨3.01%
今天 09:01
SELLAS Life Sciences Group shares are trading higher after the company reported better-than-expected Q1 EPS results.
SELLAS Life Sciences Group shares are trading higher after the company reported...
05-13 05:07
SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
SELLAS Life Sciences Group reported Q1 2026 financial results with $107.1 million in cash and $8.4 million net loss. The company highlighted progress in its Phase 3 REGAL trial for GPS in AML, nearing the 80th event milestone, and initiation of a Phase 2 trial for SLS009 in newly diagnosed AML. Preclinical data for SLS009 showed promising activity in high-risk AML subtypes. R&D expenses rose to $5.1 million, while cash increased to $107.1 million...
05-12 20:05
XOMA Royalty, Oruka Therapeutics, Repay Holdings And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, Dow Jones fell 0.1% on Monday. XOMA shares rose on Ligand's plans to acquire XOMA for $39.00/share. Other big gainers: MANE, ORKA, OGN, XE, PLBL, SLS, ANAB, EVH, IHRT, RPAY, JBIO, BEAM.
04-27 22:20
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
03-26 01:35
Sellas Life Sciences Group Files Shelf Prospectus For Offering Of Securities; No Terms Disclosed
-SEC Filing
03-21 05:14
SELLAS Life Sciences Gr Q4 EPS $(0.05) Beats $(0.07) Estimate
SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 37.5 percent increase over losses of $(0.08) per share
03-20 04:17
